Target intelligence / Profile preview

Superoxide dismutase 1 (SOD1)

Target
SOD1
Molecular classification
Enzyme, Oxidoreductase, Antioxidant
01

Overview

Superoxide dismutase 1 (SOD1), also known as Cu/Zn superoxide dismutase, is a highly abundant, homodimeric antioxidant enzyme primarily localized in the cytosol, nucleus, and mitochondrial intermembrane space. Its primary physiological function is to catalyze the dismutation of toxic superoxide radicals into molecular oxygen and hydrogen peroxide, thereby protecting cells from oxidative stress and regulating redox-sensitive signaling pathways. Mutations in the SOD1 gene are a well-established cause of familial amyotrophic lateral sclerosis (ALS), where mutant SOD1 proteins undergo pathological misfolding and aggregation, exerting a toxic gain-of-function that leads to motor neuron degeneration. In oncology, SOD1 is often overexpressed in various cancers, such as non-small cell lung cancer, where it helps tumor cells cope with elevated reactive oxygen species (ROS) levels. Therapeutically, SOD1 is targeted using different modalities depending on the disease context. In ALS, the FDA-approved antisense oligonucleotide tofersen (Qalsody) binds to SOD1 mRNA, promoting its degradation and reducing the synthesis of both wild-type and toxic mutant SOD1 proteins. In cancer, small molecule inhibitors like LCS-1 and copper-chelating agents like choline tetrathiomolybdate (ATN-224) are investigated to inhibit SOD1 enzymatic activity, leading to toxic ROS accumulation, p38 MAPK activation, and subsequent apoptosis of cancer cells.

Other names
Cu/Zn superoxide dismutase 1Superoxide dismutase [Cu-Zn]hSod1Soluble superoxide dismutase 1Cytosolic superoxide dismutase 1Indophenoloxidase AIPOAALS1
02

Mechanism of action

Antisense oligonucleotide-mediated mRNA degradation to reduce protein synthesis; small molecule enzymatic inhibition to increase intracellular reactive oxygen species and induce apoptosis

03

Biological functions

Antioxidant activitySuperoxide metabolic processResponse to oxidative stressApoptosis regulationTranscription regulationRedox signaling
04

Disease associations

Amyotrophic lateral sclerosisCancerNeurodegenerative diseaseDown syndromeParkinson's diseaseCataract
05

Safety considerations

MyelitisRadiculitisAseptic meningitisPapilledemaElevated intracranial pressureLumbar puncture-related complications (e.g., headache, back pain, cerebrospinal fluid leakage)Increased risk of cataracts or oxidative tissue damage upon complete loss of function
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

Neurofilament light chain (NfL)Cerebrospinal fluid SOD1 protein concentrationSuperoxide dismutase 1 (SOD1) gene mutation status

Beyond the preview

Go deeper on Superoxide dismutase 1 (SOD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Superoxide dismutase 1 (SOD1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call